Lv1
10 积分 2025-01-07 加入
Real-World Evaluation of Treatment Patterns and Clinical Outcomes among Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Asciminib in Clinical Practice in the United States
2天前
已完结
Asciminib as a third line option in chronic myeloid leukemia
2天前
已完结
Asciminib (Scemblix): A third-line treatment option for chronic myeloid leukemia in chronic phase with or without T315I mutation
2天前
已完结
Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study
5天前
已完结
Progress of antibody–drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies
20天前
已完结
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
1个月前
已完结
A Practical Risk Classification of Early Recurrence in Hepatocellular Carcinoma Patients with Microvascular invasion after Hepatectomy: A Decision Tree Analysis
2个月前
已完结
The past, present, and future of liver cancer research in China
2个月前
已完结
Cost‐effectiveness of first‐line systemic therapies for unresectable hepatocellular carcinoma
2个月前
已完结
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment
3个月前
已完结
皖公网安备34019202002308
